PMA

P940009: PERCUTANEUS TRANSLUMINAL CORONARY ANGIOPLASTY CATH

FDA PMA · Catheters, transluminal coronary angioplasty, percutaneous · Scimed Life Systems, Inc.

Key facts

PMA number P940009
Trade name PERCUTANEUS TRANSLUMINAL CORONARY ANGIOPLASTY CATH
Generic name Catheters, transluminal coronary angioplasty, percutaneous
Applicant Scimed Life Systems, Inc.
Product code LOX
Approval date Sep 29, 1994
Docket number 94M-0403
Notice date Dec 15, 1994
FEI number 1000221040

At a glance

  • None Supplements
  • Sep 29, 1994 Latest supplement decision
  • No Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals